Cbnaat functioning
Cbnaat mechanism

| Step | What Happens |
|---|---|
| 1. Sample preparation | The clinical specimen (sputum, CSF, pus, tissue, etc.) is mixed with a sample reagent and added to the cartridge |
| 2. Cell lysis | The cartridge's internal reagents lyse mycobacterial cells (including thick mycobacterial walls), releasing DNA |
| 3. DNA extraction | Magnetic bead-based capture purifies mycobacterial DNA from the specimen within the sealed cartridge |
| 4. PCR amplification | The instrument runs real-time PCR targeting the rpoB gene of Mycobacterium tuberculosis complex (MTBC) |
| 5. Fluorescent detection | Multiple molecular beacon probes fluoresce when they bind to amplified rpoB sequences — detected simultaneously in real-time |
| 6. Rifampin resistance detection | Five overlapping molecular beacons span the 81-bp rifampin resistance-determining region (RRDR) of rpoB; mutations causing rifampin resistance alter probe binding patterns, signaling resistance |
| 7. Automated result | The GeneXpert software interprets fluorescence data and generates a result in <2 hours |
| Feature | Detail |
|---|---|
| Time to result | <2 hours (vs. days for smear, weeks for culture) |
| Biosafety requirement | Minimal — no advanced biosafety cabinet needed |
| Training | Simple; laboratory technician can perform it |
| Specimen types | Sputum, gastric aspirate, BAL, CSF, urine, pleural biopsy, lymph node biopsy, pus |
| Automation | Fully automated — specimen preparation to result |
| Parameter | Value |
|---|---|
| Sensitivity (smear-positive pulmonary TB) | 98% |
| Sensitivity (smear-negative pulmonary TB) | ~70% |
| Specificity | 98% |
| Sensitivity for RIF resistance detection | 96% |
| Specificity for RIF resistance detection | 98% |
The Xpert MTB/RIF Ultra (next-generation cartridge on the same GeneXpert platform) improves sensitivity to ~90% overall, with a +17% gain in smear-negative, culture-positive cases, due to larger amplification chambers and two detection targets (IS6110 and IS1081 in addition to rpoB).